Retired history instructor. Alzheimer's disease researcher for the past two decades. My goal is to give investors solid advice based on the mechanisms of action of Alzheimer's drugs. This advice is ...

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is ...